DAYSI ZULEMA DIAZ-OBREGON

Dr. DAYSI ZULEMA DIAZ-OBREGON

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2026 in Diseases
Verified
Journal Article
Open access
PDF file
LQLesly Adelis Valdivia Quispe
Lesly Adelis Valdivia Quispe
LLLucio Velasco Lopez
Lucio Velasco Lopez
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
Alexis Murillo CarrascoAlexis Murillo Carrasco
Alexis Murillo Carrasco
JDJoel de León Delgado
Joel de León Delgado
CAClaudio Willbert Ramírez Atencio
Claudio Willbert Ramírez Atencio
Background/Objectives: Chemically induced hepatotoxicity is widely used in experimental research to model liver disease pathophysiology and to support preclinical studies. Thioacetamide (TAA) is a well-established hepatotoxic agent in conventional laboratory rodents; however, its effects in synanthropic rats—characterized by genetic heterogeneity and chronic environmental exposure—remain poorly defined. This study aimed to establish and characterize a preclinical model of TAA-induced hepatotoxicity in synanthropic rats and to assess its relevance for experimental liver disease research. Methods: Female synanthropic rats representing four phenotypic variants (albino, mottled, black, and brown; total n = 132) were housed under controlled conditions and assigned to control or TAA-treated groups. TAA was administered intraperitoneally at doses ranging from 200 to 300 mg/kg. Clinical parameters, including body weight and vital signs, were periodically monitored. Hematological profiles and serum biochemical markers of liver function were analyzed. Hepatic injury was evaluated by histopathological examination using hematoxylin–eosin staining. Statistical analyses were performed using R software, with p ≤ 0.05 considered statistically significant. Results: TAA-treated rats developed consistent clinical manifestations of hepatotoxicity, including progressive weight loss and reduced activity. Biochemical analyses revealed significant increases in serum transaminases, gamma-glutamyl transferase, and alkaline phosphatase, accompanied by alterations in hematological parameters. Histological evaluation demonstrated dose-dependent liver injury characterized by centrilobular necrosis, inflammatory infiltration, hepatocellular degeneration, and architectural disruption across all synanthropic rat variants. Conclusions: Synanthropic rats exhibit reproducible biochemical, hematological, and histopathological features of TAA-induced liver injury comparable to those reported in conventional laboratory strains. This model represents a robust preclinical approach for studying chemically induced hepatotoxicity and may provide enhanced translational relevance due to its genetic and environmental heterogeneity.

5 December 2025 in BMC Nephrology
Verified
Journal Article
Open access
JBJessica Bravo-Zúñiga
Jessica Bravo-Zúñiga
PSPercy Soto-Becerra
Percy Soto-Becerra
ECEdgar Juan Coila-Paricahua
Edgar Juan Coila-Paricahua
RCRicardo Chávez-Gómez
Ricardo Chávez-Gómez
EPEduardo Pérez-Tejada
Eduardo Pérez-Tejada
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
The Kidney Failure Risk Equation (KFRE) is widely used for predicting kidney failure, but its external validity in Latin America is limited. A previous study in Peru found that KFRE was miscalibrated but did not evaluate its recalibration or clinical utility. We conducted a retrospective cohort study using data from EsSalud's Renal Health Surveillance Program (2013-2022), including 30,031 patients with chronic kidney disease (CKD) stages G3-4. Kidney failure was defined by dialysis initiation or nephrologist-confirmed end-stage renal disease. Calibration was assessed using observed-to-expected (O/E) ratios and differences, calibration slope, and intercept, while discrimination was evaluated using the concordance index (C-index). Recalibrated models were developed, and decision curve analysis (DCA) was performed to evaluate clinical utility. The original KFRE demonstrated good discrimination (C-index: 0.88 at 2 years, 0.85 at 5 years) but poor calibration in-the-large: O/E ratios indicated mean underestimation of risk at 2 years (O/E ratio: 1.84) and a slight mean overestimation at 5 years (O/E ratio: 1.06). Original KFRE also had poor weak (slope: 0.58) and poor moderate calibration. Recalibrated models improved calibration in-the-large, but none achieved good weak (all slope < 1) and moderate calibration. However, DCA showed a higher net benefit for KFRE-based nephrology referrals (in original and recalibrated by method D) compared to Peruvian and international guidelines, especially over a 5-year horizon. Despite miscalibration, KFRE remains valuable for guiding nephrology referrals in Peru, with recalibrated models offering potential improvements. This is the first study in Latin America to rigorously assess the clinical utility of KFRE. Not applicable. This study is not a clinical trial.

4 July 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
POPercy Allan Vidal Orbegozo
Percy Allan Vidal Orbegozo
LGLizbeth Carmen Arce Gallo
Lizbeth Carmen Arce Gallo
IPIsabel Julia Alamo Palomino
Isabel Julia Alamo Palomino
MRMadelaine Huanca Roca
Madelaine Huanca Roca
JGJuana Eliza Ormeño Galarza
Juana Eliza Ormeño Galarza
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
Background: Chronic kidney disease (CKD) is a major public health problem, primarily affecting patients with diabetes mellitus and/or hypertension. Early detection is critical to delay progression to renal replacement therapy. Therefore, this study aims to evaluate the implementation of a digital module for CKD detection in at-risk patients within the Peruvian Social Health Insurance system (EsSalud) during 2024. Materials and Methods: Data were collected through the Renal Health Module (MOSARE), a digital tool integrated into EsSalud’s electronic health record for monitoring patients at risk of CKD. Key indicators were assessed using the RE-AIM framework: reach, effectiveness, adoption, implementation, and maintenance. Quantitative analyses evaluated patient identification, screening, and diagnosis, while qualitative analyses of technical documents identified barriers, facilitators, and stakeholder perceptions. Results: In 2024, MOSARE was implemented in a population of 1,667,856 insured individuals with CKD-related risk conditions, predominantly women (55.7%) and adults aged >55 years (88.3%). Nationwide, 93,266 patients were screened (5.59% reach), with 34.3% diagnosed with CKD. Screening coverage showed substantial geographic variability (0.35–29.59%). A total of 32,004 CKD cases were identified, with 84.2% in early stages (1–3A). Adoption reached 66.8% of level I and II healthcare facilities, with variability across networks. Regarding maintenance, 65% of trained facilities sustained active use. Implementation gaps were associated with interoperability issues, resource limitations, and training variability. Conclusions: MOSARE proved to be a feasible and operationally sensitive tool for CKD screening and risk identification, improving integration of renal care. However, addressing technical, training, and resource barriers is essential to ensure sustainability and scalability.

1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
MPMiguel Paco-Fernández
Miguel Paco-Fernández
MCMARYSELA IRENE LADERA CASTAÑEDA
MARYSELA IRENE LADERA CASTAÑEDA
MHMiguel Huamaní-Contreras
Miguel Huamaní-Contreras
Luis Adolfo CervantesLuis Adolfo Cervantes
Luis Adolfo Cervantes
César Félix Cayo-RojasCésar Félix Cayo-Rojas
César Félix Cayo-Rojas
Background: Cervical cancer is still a significant issue, especially in low‐ and middle‐income countries. Adding HPV self‐sampling to cervical cancer screening programs could make the process simpler for people to receive essential health care and support universal health coverage. Therefore, this study is aimed at mapping research output, global trends, and collaboration networks related to the implementation of HPV self‐sampling in cervical cancer screening programs. Methods: A bibliometric, descriptive, and retrospective study was performed, covering the period from 2006 to October 2025. A search was conducted in Scopus, confined to the TITLE‐ABS‐KEY fields, without language limitations, and restricted to documents in their final publication stage and original research articles. The search syntax used Boolean operators (AND, OR) to combine four thematic blocks: self‐sampling/self‐collection, etiological agent, cervical screening, and implementation and programmatic delivery. The study examined a number of indicators, such as the volume of research output, the amount of authorship credit per article, the number of normalized citations, the number of citations, the h‐index, the g‐index, and the m‐index. R (RStudio) Version 4.3.1 was used to analyze the data. Results: There were 824 articles published in 268 journals. The number of research papers published each year went up by 14.90%, and each paper received an average of 21.16 citations per year. Each paper had 8.38 coauthors, and 39.56% of the time, the coauthors were from other countries. The United States and Australia became major contributors, working together in dense networks that crossed continents. Editorial dissemination was primarily found in oncology and public health journals, with cocitation patterns connecting clinical and public health areas. The authorship distribution mirrored Lotka′s pattern, with 71.90% of authors contributing a single article and 4.10% producing five or more. The focus shifted from cytology and acceptability to molecular testing and self‐sampling from 2006 to 2011. From 2012 to 2016, the focus was more on equity and digital support tools along the screening pathway. The focus on sociocultural issues got stronger between 2017 and 2019. From 2020 to 2025, the literature began to emphasize clinical outcomes, HPV‐16, populations living with HIV, and programmatic implementation, including the collection of urine samples. Conclusion: Research on HPV self‐sampling is expanding, although it remains geographically concentrated. International collaboration is substantial, and the thematic focus has shifted toward programmatic implementation in higher‐risk populations, with increasing emphasis on equity and digital support. These patterns underscore the need for stronger translational partnerships led by stakeholders in high‐burden settings and supported by open science practices to reduce geographic disparities and inform context‐sensitive public policies.

23 August 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
ADAndrea Vanessa Llanos Diaz
Andrea Vanessa Llanos Diaz
MAMoisés Apolaya-Segura
Moisés Apolaya-Segura
OSOrlando Sevillano
Orlando Sevillano
Obert Marín SánchezObert Marín Sánchez
Obert Marín Sánchez
JVJacinto Joaquin Vértiz-Osores
Jacinto Joaquin Vértiz-Osores
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
Background: Precision nutrition and nutrigenomics have emerged as promising strategies to personalize dietary interventions according to individual genetic, metabolic, and molecular characteristics. However, the potential of nutrigenomic-guided nutraceutical interventions to modulate biological aging pathways remains poorly characterized. Objective: This study aimed to map and synthesize the available evidence from human studies evaluating personalized nutraceutical interventions based on nutrigenomic approaches and their effects on biomarkers associated with biological aging. Methods: A scoping review was conducted following the Joanna Briggs Institute methodology and PRISMA-ScR guidelines. PubMed/MEDLINE, Embase, Scopus, and Web of Science were searched for studies published between 2021 and 2026. Eligible studies included adults aged ≥18 years receiving personalized nutraceutical interventions informed by genetic, genomic, metabolomic, or other molecular data. Outcomes included biomarkers of cellular aging, inflammation, oxidative stress, immunometabolism, and related pathways. Results: Twenty-one studies were included. Interventions involved omega-3 fatty acids, polyphenols, Nigella sativa, vitamin D, methyl-donor micronutrients, fermented papaya preparation, and other nutraceutical preparations and functional food-based interventions. Four major themes emerged: multi-omic stratification approaches, biological aging biomarkers, redox-inflammatory modulation, and applications in metabolic disorders. Most studies demonstrated favorable effects on intermediate molecular biomarkers, including inflammatory cytokines, oxidative stress markers, lipid metabolism, endothelial function, and DNA methylation signatures. However, evidence directly demonstrating slowing of biological aging through validated biomarkers such as epigenetic clocks or telomere dynamics remains limited. Conclusions: Personalized nutraceutical interventions exhibit biological plausibility for modulating pathways associated with healthy aging. Nevertheless, robust longitudinal studies incorporating validated biomarkers of biological aging and clinically meaningful outcomes are needed before their widespread implementation in precision medicine.

1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
MPMiguel Paco-Fernández
Miguel Paco-Fernández
MCMARYSELA IRENE LADERA CASTAÑEDA
MARYSELA IRENE LADERA CASTAÑEDA
DDDAYSI ZULEMA DIAZ-OBREGON
DAYSI ZULEMA DIAZ-OBREGON
Luis Adolfo CervantesLuis Adolfo Cervantes
Luis Adolfo Cervantes
César Félix Cayo-RojasCésar Félix Cayo-Rojas
César Félix Cayo-Rojas
Background: This study is aimed at conducting a bibliometric analysis of avoidable mortality from 2000 to 2024 to identify collaboration networks, research trends, and scientific impact in this field. Methods: A bibliometric, descriptive, and retrospective study was conducted using the Scopus Advanced Search interface, controlled vocabulary related to avoidable mortality, and Boolean operators (“AND” and “OR”). Analyses were performed in R (v4.3.1) using the bibliometrix/biblioshiny package and included indicators of publication volume, fractional authorship, total normalized citations, citation counts, and the h ‐, g ‐, and m ‐indexes. International collaboration was assessed using coauthorship indicators and collaboration networks. Bradford′s law was applied to identify core journals. In addition, keyword co‐occurrence networks and thematic temporal evolution were examined to characterize research fronts and shifts over time. Results: A total of 3031 documents from 1450 journals were retrieved, with an annual growth rate of 9%. On average, articles received 27.8 citations, totaling approximately 84,000 citations overall. Authors had an average of 5.2 coauthors per article, and 244 single‐authored papers were identified. International coauthorship accounted for 23.8% of publications. The United States and the United Kingdom published most frequently in PLOS ONE and BMJ Open. Coauthorship networks revealed weak intergroup connections, with international collaboration concentrated along the US–Western Europe axis. Brazil and South Africa emerged as key regional nodes in the Global South. The thematic focus evolved from prevention‐ and health‐service–related topics to population profiles and injury, and more recently to COVID‐19–related terminology and pregnancy. Conclusion: This bibliometric analysis demonstrates a rising interest in avoidable mortality, reflected in increased scientific output and limited intergroup connectivity within international collaboration networks. Only a limited number of authors consistently contribute impactful research in both general and specialized journals. These findings highlight the importance of fostering collaborative, high‐quality translational research to inform public policy and address the regional determinants of avoidable mortality, particularly in the Global South.